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Abstract
Of the over 250 Aspergillus species, Aspergillus fumigatus accounts for up to 80% of invasive
human infections. A. fumigatus produces galactosaminogalactan (GAG), an exopolysacchar-
ide composed of galactose and N-acetyl-galactosamine (GalNAc) that mediates adherence
and is required for full virulence. Less pathogenic Aspergillus species were found to produce
GAGwith a lower GalNAc content than A. fumigatus and expressed minimal amounts of cell
wall-bound GAG. Increasing the GalNAc content of GAG of the minimally pathogenic A. nidu-
lans, either through overexpression of the A. nidulans epimerase UgeB or by heterologous
expression of the A. fumigatus epimerase Uge3 increased the amount of cell wall bound
GAG, augmented adherence in vitro and enhanced virulence in corticosteroid-treatedmice to
levels similar to A. fumigatus. The enhanced virulence of the overexpression strain of A. nidu-
lanswas associated with increased resistance to NADPH oxidase-dependent neutrophil
extracellular traps (NETs) in vitro, and was not observed in neutropenic mice or mice deficient
in NADPH-oxidase that are unable to form NETs. Collectively, these data suggest that cell
wall-bound GAG enhances virulence throughmediating resistance to NETs.
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Author Summary
The ubiquitous mold A. fumigatus is isolated in over 80% of all patients with invasive
aspergillosis (IA). A. nidulans is a relatively non-pathogenic species that rarely causes IA
except in patients with chronic granulomatous disease (CGD), a hereditary disease charac-
terized by impaired neutrophil function due to mutations in the NADPH oxidase complex.
Here, we demonstrate that one factor underlying the differences in the intrinsic virulence
between A. fumigatus and A. nidulans is the amount of the exopolysaccharide galactosami-
nogalactan that is associated with the cell wall of these species. A. fumigatus produces
higher amounts of cell wall-associated galactosaminogalactan and is more resistant than
A. nidulans to neutrophil killing by NADPH-oxidase dependent extracellular traps
(NETs). Increasing cell wall-associated galactosaminogalactan in A. nidulans enhanced
resistance to NETs and increased the virulence of this species to the same level as A. fumi-
gatus in mice with intact NET formation. Collectively, these data suggest that A. nidulans
is more sensitive than A. fumigatus to NADPH-oxidase dependent NETosis due to lower
levels of cell wall-associated GAG.
Introduction
Invasive aspergillosis (IA) is the most common invasive mold infection in humans. In immu-
nocompromised patients, the inhalation of airborne spores of Aspergillus species leads to a nec-
rotizing fungal pneumonia that can disseminate hematogenously to the brain and other organs
[1]. Although the genus Aspergillus is comprised of over 250 members, Aspergillus fumigatus is
responsible for more than 80% of invasive aspergillosis cases [2]. On the other hand, Aspergillus
nidulans is a model, non-pathogenic organism used extensively for the study of eukaryotic cell
biology. Interestingly, A. nidulans is rarely a cause of invasive disease, except in patients with
chronic granulomatous disease (CGD), a genetic disorder of the NADPH oxidase system that
results in impaired production of reactive oxygen species by phagocytes [3–6]. The predomi-
nance of A. fumigatus as a cause of invasive disease in patients without CGD is not reflected in
air or environmental sampling studies in which A. fumigatus accounts for only a minority of
the total Aspergillus species recovered [7]. These observations suggest that A. fumigatus pos-
sesses unique virulence traits that enhance its ability to cause human infection. Disruption of a
number of putative virulence factors of A. fumigatus results in attenuated virulence of this spe-
cies (reviewed in [7,8]). However, none of these factors have been demonstrated to confer
increased virulence on less pathogenic Aspergillus species such as A. nidulans. The identifica-
tion of this type of transferable virulence factor would improve our understanding of the path-
ogenesis of IA, and could potentially guide the development of novel therapeutic strategies.
Recently, we and others have reported that the secreted and cell wall exopolysaccharide
galactosaminogalactan (GAG) is required for normal virulence of A. fumigatus [9,10]. GAG is
an α-1,4-linked linear heteroglycan composed of a variable combination of galactose and N-
acetyl-galactosamine (GalNAc). Although the pathways governing GAG synthesis are not fully
understood, two UDP-glucose 4-epimerases, Uge5 and Uge3, are required for GAG produc-
tion. Uge5 mediates the conversion of UDP-glucose to UDP-galactose, while Uge3 is a bifunc-
tional epimerase that can mediate both the interconversion of UDP-glucose to UDP-galactose
and of UDP-N-acetylglucosamine to UDP-GalNAc [11]. Deletion of uge5 results in the pro-
duction of GAG with a lower galactose content, while deletion of uge3 completely abrogates
GAG synthesis [10,11]. GAG plays a number of roles in host-pathogen interactions [9,10].
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This glycan mediates adherence to a variety of substrates, including host cells, and is required
for normal biofilm formation [12]. Also, GAG covers the surface of hyphae to conceal β-
1,3-glucans from recognition by the pattern recognition receptor dectin-1 leading to decreased
pulmonary inflammation [10]. Purified, soluble GAG also induces natural killer (NK) cell-
mediated apoptosis of neutrophils in vitro [13], and administration of soluble GAG is immu-
nosuppressive through the induction of IL-1RA production [14]. Consistent with the patho-
genic function of GAG, a GAG-deficient A. fumigatusmutant was found to have attenuated
virulence in a mouse model of invasive aspergillosis [10]. Synthesis of linear α-1,4-linked GAG
has been reported in other Aspergillus species, including A. parasiticus [15], A. niger [16], and
A. nidulans [17,18], although the quantity of GAG from these species has not been compared.
In light of the important role that GAG plays in the virulence of A. fumigatus, we investigated
whether differences in GAG production or composition might contribute to the spectrum of
virulence observed among Aspergillus species.
Results
A. fumigatusGAG contains higher levels of GalNAc than GAG produced
by other Aspergillus species
To determine if different species of Aspergillus produce different levels of secreted GAG, we
investigated two medically relevant species, A. fumigatus as well as A. flavus, which is the sec-
ond most common Aspergillus isolate in IA patients [19]. We also studied the less pathogenic
A. niger and A. nidulans. When these organisms were grown under GAG-inducing conditions,
all species secreted similar amounts of GAG into the medium, as recovered by ethanol precipi-
tation (S1A Fig). However, scanning electron microscopy (SEM) of hyphae from each of these
Aspergillus species demonstrated dramatic differences in the amount of GAG-associated deco-
rations on the cell wall of hyphae (Fig 1A) [10]. A. fumigatus displayed abundant cell wall-
bound decorations, while the other species more closely resembled the previously described A.
Fig 1. Production of GalNAc-rich GAG correlates with reported virulence of Aspergillus spp. (A) Scanning electron micrograph of hyphae of indicated
species at 20,000Xmagnification. Arrows indicate surface decorations associated with cell wall-bound GAG. The GAG deficient A. fumigatus Δuge3mutant
[10] and the A. fumigatus ΔstuAmutant [49] which produces only minimal amounts of GAG are included for comparison purposes. (B) Cell wall GalNAc
staining with FITC-conjugated soybean agglutinin (SBA). SBA binding to mature hyphal mats of the indicated species was quantified by fluorometry. Data are
represented as mean +/- SEM. * indicates a significant difference between A. fumigatus and other species, p<0.05 by ANOVA and pairwise comparison.
doi:10.1371/journal.ppat.1005187.g001
Galactosaminogalactan Mediates Resistance to NETs
PLOS Pathogens | DOI:10.1371/journal.ppat.1005187 October 22, 2015 3 / 22
fumigatus ΔstuAmutant, which produces very low levels of GAG (Fig 1A) [10]. To confirm
that the alterations in cell wall morphology reflected changes in the amount of cell wall-associ-
ated GAG, the amount of cell wall-bound GAG was examined by staining hyphae of each of
the Aspergillus species with the GalNAc specific lectin, soybean agglutinin (SBA) [10,11,20,21].
Staining of cell wall-bound GalNAc by SBA was strongest with A. fumigatus, followed by A. fla-
vus, while A. niger and A. nidulans exhibited minimal SBA binding (Fig 1B). Importantly, simi-
lar levels of hyphal cell wall SBA staining were observed with the commonly used A. nidulans
laboratory strain A26 and three other clinical isolates of this species (S1B and S1C Fig),. Inter-
estingly, the amount of GalNAc-rich GAG and cell wall decorations produced by these species
paralleled their frequency of recovery from patients with invasive aspergillosis. Collectively,
these results suggest that Aspergillus species exhibit significant differences in the amount of cell
wall-associated GAG. Moreover, these differences correlate with the reported intrinsic viru-
lence of these species. In light of these findings, A. fumigatus and A. nidulans A26 were selected
for further study as representatives of highly pathogenic and minimally pathogenic species of
Aspergillus species that display significant differences in cell wall-bound GAG.
A. nidulans produces GalNAc-poor GAG and has impaired biofilm
formation as compared with A. fumigatus
To test if the degree of cell wall-bound GAG could reflect differences in the composition of
GAG produced by A. fumigatus and A. nidulans, monosaccharide analysis of secreted GAG
from both species was performed by gas chromatography. Secreted GAG produced by A. nidu-
lans contained significantly less GalNAc and more galactose as compared with A. fumigatus
GAG (Fig 2A).
To test if the production of lower GalNAc-containing GAG by A. nidulans could affect the
known virulence-associated properties of GAG, A. nidulans was compared with A. fumigatus
with respect to its ability to form adherent biofilm and to mask hyphal β-glucan exposure. A.
nidulans A26 and three clinical isolates of A. nidulans formed less adherent biofilms (Figs 2B
Fig 2. nidulans produces GalNAc-poor GAGwhich is associated with non-adherence. A. (A) Galactose and GalNAc content of secreted GAG from
either A. fumigatus or A. nidulans as identified by gas chromatography and quantified by hexose or hexosamine assays. (B) Formation of adherent biofilms
on tissue culture-treated polystyrene plates by A. fumigatus and A. nidulans. After 24 hours growth, biofilms were washed and visualized by staining with
0.1% crystal violet. (C) Detection of β-1,3-glucan exposure on the surface of hyphae by immunostaining with Fc-dectin-1 antibody by fluorometry. (D)
Relative expression of ugeB in A. nidulans and uge3 in A. fumigatus, during growth in Brian medium as measured by real-time RT-PCR. Expression of tef1
from each respective species was used as an internal reference gene. Primer efficiency was verified, and was not different between species (S2E Fig). For all
panels: data are represented as mean +/- SEM. AfWT indicates A. fumigatus, and AnWT indicates A. nidulans. * indicates a significant difference between A.
fumigatus and A. nidulans, p<0.05 by Student t test or ANOVA with Tukey’s test for pairwise comparison, where applicable.
doi:10.1371/journal.ppat.1005187.g002
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and S1) as compared with A. fumigatus. In contrast, β-glucan binding by recombinant Fc-dec-
tin-1 was not different between these two species (Fig 2C). These observations suggest that the
quantity of cell wall bound GAG as well as the ability of GAG to mediate biofilm formation are
dependent on the GalNAc content of GAG. In contrast, β-glucan masking appears to be Gal-
NAc-independent, or at least require a lower amount of this hexosamine.
A. nidulans produces GAG with a lower GalNAc content due to low
levels of expression of the glucose epimerase UgeB
The synthesis of the GalNAc component of GAG in A. fumigatus results from the activity of
the UDP-glucose 4-epimerase, Uge3 [10,11]. A search of the A. nidulans genome identified
ugeB as the gene whose product has the closest homology to A. fumigatus Uge3 (85% amino
acid identity). As with the A. fumigatus uge3 gene [10], deletion of ugeB in A. nidulans resulted
in a strain whose hyphae lacked detectable GalNAc by SBA staining (S2A Fig), confirming that
Uge3 and UgeB both mediate GalNAc synthesis. Consistent with a previous report that ugeB
expression is extremely low in A. nidulans [22], real-time RT-PCR demonstrated that the
expression of ugeB in A. nidulans was significantly lower than the expression of uge3 in A.
fumigatus (Fig 2D), suggesting that the lower GalNAc content of GAG produced by A. nidu-
lansmay be due to the lower expression levels of ugeB. As expected, expression of uge3 was not
detected in A. nidulans (S2B Fig).
Overexpression of uge3 or ugeB in A. nidulans increases the GalNAc
content and cell wall binding of GAG, as well as enhances biofilm
formation
To test the hypothesis that the low GalNAc content of A. nidulans GAG results from low
expression of ugeB, strains of A. nidulans were constructed in which the A. fumigatus uge3 or
A. nidulans ugeB genes were expressed under the constitutively active gpdA promoter to pro-
duce strains An-Uge3 and An-UgeB, respectively (Fig 3A). Overexpression of either uge3 or
ugeB had no significant effect on total secreted GAG production (Fig 3B). However, increased
expression of either gene resulted in an increase in the GalNAc content of secreted GAG (Fig
3C) to levels similar to that found in A. fumigatus. Even more dramatically, overexpression of
either gene markedly increased the amount of cell wall-bound GAG as detected by SBA lectin
binding (Fig 3D) and SEM to levels indistinguishable from A. fumigatus (Fig 3E). These data
suggest that the GalNAc content of GAG is important in determining the amount of GAG that
binds to the hyphal cell wall.
Augmenting the GalNAc content of GAG in A. nidulans resulted in a marked increase in
biofilm formation (Fig 3F), but had no effect on the size or germination of the conidia (S2C
and S2D Fig), β-1,3-glucan masking (Figs 3G and S2F), or hyphal growth rate (S2G Fig). Col-
lectively, these data suggest that increasing GalNAc content of A. nidulans GAG by overexpres-
sing either the native A. nidulans ugeB or A. fumigatus uge3 gene resulted in a strain of A.
nidulans that resembled A. fumigatus, in vitro.
Increasing the GalNAc content of A. nidulansGAG increases the
virulence of A. nidulans
To determine if the increase in cell wall-bound GalNAc-rich GAG resulting from overexpres-
sion of either uge3 or ugeB could result in increased virulence, corticosteroid-treated Balb/c
and C57BL/6 mice were infected intranasally with wild-type A. fumigatus, wild-type A. nidu-
lans, An-Uge3, or An-UgeB. As expected, mice infected with wild-type A. nidulans had a
Galactosaminogalactan Mediates Resistance to NETs
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longer median survival than those infected with A. fumigatus (Fig 4A and 4B). Also, 10–25% of
mice infected with wild-type A. nidulans survived to the end of the experiment, whereas none
of the animals infected with A. fumigatus survived. In contrast, the onset of death, median sur-
vival and overall mortality of mice infected with An-Uge3 or An-UgeB were similar to mice
infected with A. fumigatus. Similar findings were observed in Balb/c (Fig 4A) and C57BL/6
mice (Fig 4B), suggesting these differences in virulence were not mouse strain specific. Thus,
increasing the GalNAc content of GAG in A. nidulans by increasing expression of a heterolo-
gous or endogenous GalNAc epimerase significantly enhanced the virulence of this minimally
pathogenic Aspergillus species.
Fig 3. Overexpression of uge3 or ugeB in A. nidulans increases the GalNAc content of GAG and enhances the formation of adherent biofilms. (A)
Relative expression of uge3 in the An-Uge3 strain and ugeB in the An-UgeB strain compared to the expression level of ugeB in wild-type A. nidulans grown in
Brian medium and as measured by real-time RT-PCR. (B) Total amount of secreted GAG from the indicated strains. (C) GalNAc content of secreted GAG
from the indicated strains as determined by gas chromatography and quantified by hexose or hexosamine assays. (D) Cell wall GalNAc staining with FITC-
conjugated soybean agglutinin (SBA). SBA binding to mature hyphal mats of the indicated strains was quantified by fluorometry. (E) Scanning electron
micrograph of hyphae of indicated species at 20,000Xmagnification. Arrows indicate surface decorations associated with cell wall-bound GAG. (F)
Formation of adherent biofilms on tissue culture treated polystyrene plates by the indicated strains. After 24 hours growth, biofilms were washed and
visualized by staining with 0.1% crystal violet. (G) Detection of β-1,3-glucan exposure on the surface of hyphae by immunostaining with Fc-dectin-1 antibody
labeled with FITC secondary antibody and quantified by fluorometry at 495 nm. For all panels: An-Uge3 indicates the A. nidulans overexpressing uge3 strain;
An-UgeB indicates the A. nidulans overexpressing ugeB strain; and AnWT indicates wild type A. nidulans. Data are represented as mean +/- SEM and *
indicates a significant difference between A. nidulans, and both overexpression strains, p<0.05 by ANOVA with Tukey’s test for pairwise comparison.
doi:10.1371/journal.ppat.1005187.g003
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Increasing the GalNAc content of A. nidulansGAG resulted in increased
tissue invasion
To examine the mechanisms underlying the increased virulence seen with overexpression of
uge3 or ugeB in A. nidulans, corticosteroid-treated mice were infected with wild-type A. nidu-
lans or An-Uge3 and their lungs examined after 4 days of infection. The pulmonary fungal bur-
den of mice infected with An-Uge3 was significantly higher than in mice infected with wild-
type A. nidulans, as measured by galactomannan content (Fig 5A) and quantitative morpho-
metric analysis of histopathology sections (Fig 5B). Histopathologic examination of lungs from
these mice revealed striking differences in the degree of pulmonary invasion between wild-type
A. nidulans (Fig 5C, top) and An-Uge3 (Fig 5C, bottom). Hyphae of wild-type A. nidulans
were largely restricted to the airway lumen with minimal penetration into the pulmonary
parenchyma. In contrast, hyphae of the An-Uge3 strain were markedly more invasive and pen-
etrated significantly deeper into pulmonary tissues. Quantitative morphometric analysis of his-
topathology sections confirmed that hyphae of the An-Uge3 strain invaded much further from
the airways than the parental A. nidulans strain (Fig 5D). Importantly, the magnitude of tissue
invasion by the An-Uge3 strain (5-fold (Fig 5D)) was much greater than the increase in total
lesion size (1.5-fold (Fig 5B)), suggesting that the increased invasiveness was not simply a
reflection of increased lesion size. In fact, in mice infected with the An-Uge3 overexpression
strain, only 2 out of 51 lesions remained confined within the airway lumen compared to 18 out
of 51 lesions from mice infected with wild-type A. nidulans. Further histological examination
by immunohistochemistry with anti-GAG antibody revealed that the hyphal surface of An-
Uge3 hyphae in these lesions was associated with increased cell wall-bound GAG, consistent
with in vitro observations (Fig 5E). These results suggest that increasing the GalNAc content of
GAG in A. nidulans increases cell wall-associated GAG, and enhances the growth of hyphae
within pulmonary tissues.
Cell wall-associated GAG has been reported to modulate immune responses through the
masking of hyphal PAMPs [10]. Additionally, soluble GAG has been found to directly induce
neutrophil apoptosis and the induction of IL-1RA production by macrophages [9,14]. Multiple
parameters of the host inflammatory response were therefore analyzed in lungs of infected
mice to determine if An-Uge3 induced a different response than wild-type A. nidulans. No sig-
nificant differences were observed between mice infected with A. nidulans or the An-Uge3
Fig 4. Overexpression of uge3 in A. nidulans increases virulence in mice. (A) Survival of corticosteroid treated BALB/c mice infected with the indicated
conidial species and strains. Data represent the results from two independent experiments for total N = 20 for A. nidulans or An-Uge3; N = 10 for A. fumigatus
or An-UgeB; N = 8 for PBS control. (B) Survival of corticosteroid treated C57BL/6 mice infected with the indicated conidial species and strains. Five or more
mice were infected for each group. * indicates a significant difference in survival of A. nidulans compared with A. fumigatus, An-Uge3, and An-UgeB
overexpression strains as determined by the Mantel-Cox log-rank test with pairwise comparison applying Bonferroni correction.
doi:10.1371/journal.ppat.1005187.g004
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strain with respect to total leukocyte (Fig 5F) or neutrophils (Fig 5G) in the lungs of infected
mice. Analysis of the bronchoalveolar lavage fluid also revealed no significant differences
Fig 5. Increase in virulence of the A. nidulans strain overexpressing uge3 is associated with increase in fungal burden and pulmonary tissue
invasion. (A) Pulmonary fungal burden measured by relative galactomannan content in the lungs of mice infected with the indicated strains, N = 10 Balb/c
mice for each fungal strain. (B) Total fungal lesion size as determined by morphometric analysis of lung histopathology for the indicated strains, N = 4 Balb/c
mice for each fungal strain. (C) Pulmonary histopathology sections from Balb/c mice infected with indicated strains and stained with PAS for visualization of
fungi. The yellow dotted line indicates the limit of the airway used for morphometric analysis. White arrow indicates fungal elements outside the airway and
invading into pulmonary tissues. Scale bar represents 100 μm (black) or 50 μm (white). (D) Lesion invasion beyond the airway as determined by
morphometric analysis of infected mouse lung histopathology for the indicated strains, N = 4 Balb/c mice for each fungal strain. (E) Pulmonary histopathology
sections from Balb/c mice infected for 4 days with the indicated strains and labeled with an anti-GAG antibody to visualize GAG on hyphae. Arrow indicates
hyphae. Scale bar represents 80 μm (black) or 30 μm (white). (F) Total pulmonary leukocytes frommice 4 days after infection with the indicated strains as
measured by CD45 detection by flow cytometry. N = 10 Balb/c mice for each fungal strain, N = 5 for PBS control. (G) Total pulmonary neutrophils from of
mice 4 days after infection with the indicated strains as measured by Ly6G+, CD11bhigh, and CD11clow detection using flow cytometry. N = 10 Balb/c mice for
each fungal strain, N = 5 Balb/c mice for PBS control. (H) Pulmonary histopathology sections from Balb/c mice 4 days after infection with the indicated strains
and labeled with anti-caspase-3 antibody to visualize host cells undergoing apoptosis. Arrow indicates hyphae. Scale bar represents 100 μm (black) or
50 μm (white). For all panels: An-Uge3 indicates the A. nidulans overexpressing uge3 strain and AnWT indicates wild type A. nidulans. For panel A, B, D, F,
and G, data are represented as median with interquartile ranges and * indicates a significant difference between A. nidulans and the An-Uge3 strain, p<0.05
by Kruskal-Wallis test with Dunn’s test for pairwise comparison.
doi:10.1371/journal.ppat.1005187.g005
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between mice infected with A. nidulans or the An-Uge3 strain with respect to total leukocytes
or neutrophils, (S3A and S3B Fig); or total lung myeloperoxidase, TNF-α, IL-1β, IL-17 and IL-
1RA levels (S3C–S3G Fig). In addition, no differences in the number of live or dead leukocytes
or neutrophils were found between mice infected with wild-type A. nidulans or the An-Uge3
strain (S3H and S3I Fig). Further, histopathological examination of fungal lesions did not iden-
tify any differences in leukocyte nuclear fragmentation surrounding fungal lesions suggestive
of differences in apoptosis (S3J Fig), and immunohistochemical staining for caspase-3 did not
demonstrate differences between lesions resulting from these two strains (Fig 5H). Taken
together, these results suggest that altering the amount of cell wall-bound GAG in A. nidulans
does not alter virulence by altering the host inflammatory response.
Increasing cell wall-associated GAG enhances resistance to neutrophil
killing in vitro
Increasing the GalNAc content of GAG in A. nidulansmarkedly increased the amount of poly-
saccharide bound to the hyphal surface and was associated with increased fungal growth and
invasion in vivo. In light of these findings, we hypothesized that cell wall-associated GAG
might function like a capsule and mediate resistance to neutrophil damage during infection.
We therefore examined the ability of primary human neutrophils to damage hyphae of A.
fumigatus, A. nidulans and the An-Uge3 strain. Consistent with our observations in vivo, A.
nidulans was more susceptible to damage by neutrophils than A. fumigatus or the An-Uge3
strain (Fig 6A), suggesting that cell wall-associated GAG enhances resistance to neutrophil
killing.
Increasing cell wall-associated GAG enhances resistance to ROS-
independent, NADPH oxidase-dependent neutrophil damage
To probe the mechanism underlying the enhanced resistance of GAG-producing Aspergillus to
neutrophil-mediated damage, primary human neutrophils were treated with the NADPH oxi-
dase inhibitor, diphenylene iodonium (DPI), and incubated with the fungal strains. Differences
in fungal strain susceptibility to neutrophil mediated damage were lost when neutrophils were
treated with DPI (Fig 6A). This observation suggests that the cell wall-associated GAG medi-
ates resistance to NADPH oxidase-dependent neutrophil killing. Since NADPH oxidase medi-
ates production of reactive oxygen species, hyphal susceptibility to hydrogen peroxide was
examined. Surprisingly. A. nidulans and the An-Uge3 strain were equally resistant to oxidative
stress and significantly more resistant than A. fumigatus (Fig 6B). These findings suggest that
cell wall-associated GAG mediates resistance to NADPH oxidase-dependent neutrophil killing,
but not by directly enhancing resistance to reactive oxygen species.
Increasing cell wall-associated GAG enhances resistance to neutrophil
extracellular traps (NETs)
In addition to mediating the production of reactive oxygen species that directly injure fungi,
phagocyte NADPH oxidase also mediates antifungal host defense by inducing the coordinated
release of DNA and antimicrobial peptides from neutrophil granules to form neutrophil extra-
cellular traps (NETs) [23,24]. NADPH-oxidase dependent NET formation has been reported
in response to both A. fumigatus and A. nidulans, in vitro and in vivo [25–28]. To determine if
NET formation correlated with the differences in GAG-dependent susceptibility of strains to
neutrophil killing, primary neutrophils were co-cultured with A. fumigatus, A. nidulans and
An-Uge3 and examined for NET formation (Fig 7A). Nuclear de-condensation and the
Galactosaminogalactan Mediates Resistance to NETs
PLOS Pathogens | DOI:10.1371/journal.ppat.1005187 October 22, 2015 9 / 22
formation of propidium iodide staining NETs were observed during co-culture with all three
organisms (Fig 7A). Although the number of neutrophils undergoing NETosis was not differ-
ent in response to the different fungal strains, more propidium iodide positive NETs were
bound by hyphae of wild-type A. nidulans compared with A. fumigatus or An-Uge3 (Fig 7A).
Treatment of primary human neutrophils with micrococcal nuclease (MNase), which degrades
DNA, prevented the formation of NETs as previously reported [29], and reduced the differ-
ences in susceptibility to neutrophil-mediated damage among the three Aspergillus strains (Fig
7B), mirroring the effects of DPI treatment. Similarly, neutrophils isolated from a patient with
CGD failed to form NETs, and did not exhibit enhanced killing of A. nidulans relative to A.
fumigatus or An-Uge3 (Fig 7C), reproducing the effects of DPI and MNase treatment. Consis-
tent with the differences in strain virulence seen in the corticosteroid-treated mouse model,
corticosteroid treated primary neutrophils formed NETs and retained their ability to kill wild-
type A. nidulans to a greater degree than A. fumigatus or An-Uge3, (Fig 7D). Finally, wild-type
A. nidulans was also found to be more susceptible to primary neutrophil lysates than A. fumi-
gatus or the An-Uge3 strain (Fig 8A), confirming that cell wall-bound GAG directly mediates
resistance to damage by neutrophil contents contained within NETs. Interestingly, similar pat-
terns of differential susceptibility to damage were also seen with lysates collected from DPI-
treated human neutrophils, as well as primary neutrophils from C57BL/6 mice and primary
neutrophils from NADPH-oxidase deficient mice (Fig 8C and 8D). These observations suggest
that, under these conditions, neutrophil NADPH oxidase exerts its antifungal activity largely
by orchestrating release of neutrophil intracellular contents, rather than influencing their com-
position or activity. Collectively these data suggest that cell wall-bound GAG enhances resis-
tance to NADPH oxidase-dependent neutrophil extracellular damage by directly increasing
resistance to NETs.
Fig 6. Increasing cell wall-associated GAG enhances the resistance of A. nidulans to NADPH oxidase-
dependent neutrophil extracellular traps (NETs) but not reactive oxygen species. (A) Fungal injury by
primary human neutrophils (PMN) either untreated (black bars) or treated with the NADPH oxidase inhibitor
diphenyleneiodonium (DPI) (gray bars). (B) Susceptibility of the indicated fungal strains to injury after
treatment with 3.2 mM hydrogen peroxide. * indicates a significant difference between A. nidulans and A.
fumigatus or An-Uge3 strains, p<0.05 by ANOVA with Tukey’s test for pairwise comparison. § indicates a
significant difference in killing of A. nidulans between DPI-treated and untreated neutrophils, p<0.05 by
ANOVA with Tukey’s test for pairwise comparison.
doi:10.1371/journal.ppat.1005187.g006
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Fig 7. Inhibition or disruption of NETs attenuates the susceptibility of A. nidulans to killing by human neutrophil-mediated killing. (A) Neutrophil
extracellular traps formation by primary human PMN as visualized by the DNA intercalating agent propidium iodide. Arrows indicate the increased binding of
propidium iodide stained NETs on the surface of wild-type A. nidulans hyphae. Images were acquired using a 543 nm laser and detected by confocal
microscopy at 600X magnification with 4X digital zoom. Scale bar represents 10 μm. (B) Susceptibility of fungal strains to injury by PMNs in the presence
(gray bars) or absence (black bars) of micrococcal nuclease (MNase). (C) Susceptibility of fungal strains to injury by PMNs from healthy donor (black bars) or
from a CGD patient (grey bars). (D) Susceptibility of fungal strains to injury by PMNs pre-treated with 10 μM dexamethasone (grey bars) or untreated (black
bars). * indicates a significant difference between A. nidulans and A. fumigatus or An-Uge3 strains, p<0.05 by ANOVA with Tukey’s test for pairwise
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To test if GAG-mediated resistance to NETs underlies the increased virulence of the An-
Uge3 strain (Fig 4), we compared the virulence of wild-type A. nidulans and the An-Uge3
strain in two groups of mice that cannot make NETs in response to Aspergillus infection: neu-
tropenic mice and gp91phox deficient mice, that lack functional NADPH oxidase [26]. Consis-
tent with our in vitro findings, increasing cell wall-associated GAG expression in the An-Uge3
strain did not increase A. nidulans virulence in either of these NET deficient mice (Fig 9A and
9B). These data strongly suggest that the expression of cell wall-bound GAG by Aspergillus
mediates virulence through enhancing resistance of hyphae to NADPH oxidase-dependent
NET formation.
Discussion
This study establishes a role for cell wall-associated GAG in mediating resistance to killing of
Aspergillus by NETs and provides the first example of a virulence factor of A. fumigatus that is
able to mediate enhanced virulence when expressed in a less pathogenic Aspergillus species.
GAG has been reported to mediate a number of functions in vitro that could influence viru-
lence, including host cell adherence, masking of β-glucan, the modulation of host immune
responses and the induction of neutrophil apoptosis [10,13,14,34]. While determining the con-
tribution of each of these mechanisms to virulence is challenging, the present study provides
some insights into this question. First, β-glucan masking was not different among A. fumigatus
comparison. § indicates significant difference treatment groups of PMNs co-incubated with A. nidulans, p<0.05 by ANOVA with Tukey’s test for pairwise
comparison. All data are represented as mean +/- SEM.
doi:10.1371/journal.ppat.1005187.g007
Fig 8. GAG-mediated resistance to neutrophil killing is dependent on neutrophil lysate content. Susceptibility of fungal strains to injury by lysates
derived from, (A) primary human neutrophils, (B) primary human neutrophils treated with DPI., (C) primary C57BL/6 mouse neutrophils or gp91phox deficient
(CGD) mouse neutrophils. * indicates a significant difference between A. nidulans and A. fumigatus or An-Uge3 strains, p<0.05 by ANOVAwith Tukey’s test
for pairwise comparison.
doi:10.1371/journal.ppat.1005187.g008
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A. nidulans and the An-Uge3 strains in our study, suggesting that differences in β-glucan
masking and dectin-1 activation do not contribute to the difference in virulence between these
strains. Second, the similar levels of virulence exhibited by wild-type A. nidulans and the An-
Uge3 strain in neutropenic and NADPH-oxidase deficient mice suggests that increased biofilm
formation by the overexpression strain does not play a significant role in virulence. Finally,
increasing the amount of cell wall-bound GAG enhanced Aspergillus virulence in the absence
of any detectable difference in inflammation or immune response, including pulmonary IL-
1RA levels, neutrophil recruitment to site of infection, and the induction of neutrophil apopto-
sis, which have been observed during treatment with soluble GAG [13,14]. The failure to
observe changes in these responses in the present study likely reflects the fact that these effects
of GAG were observed in response to treatment with soluble GAG. In the experiments reported
here, the amount of shed, soluble GAG was not different between the three strains of Aspergil-
lus and only the quantity of cell wall-bound GAG differed among these strains.
Multiple lines of evidence suggest that increased cell wall-associated GAG production aug-
ments virulence in non-neutropenic mice through enhancing resistance to neutrophil contents
released as extracellular traps. The higher levels of cell wall-bound GAG in A. fumigatus and
An-Uge3 increased resistance to damage by neutrophils and by neutrophil lysates, but not by
toxic reactive oxygen species. Moreover, differences in susceptibility to neutrophil mediated
damage among A. fumigatus, wild-type A. nidulans, and the An-Uge3 strain were not seen
Fig 9. GAGmediated enhancement of A. nidulans virulence requires functional leukocyte NADPH
oxidase. (A) Survival of leukopenic mice infected with either A. nidulans or An-Uge3 conidia. N = 9 per
infection group. (B) Survival of gp91phox deficient mice lacking functional NADPH oxidase infected with either
A. nidulans or An-Uge3 conidia. N = 17 per infection group. For all panels: An-Uge3 indicates the A. nidulans
overexpressing uge3 strain; AnWT indicates wild type A. nidulans; and AfWT indicates wild type A.
fumigatus. n.s. indicates no significant difference in survival of A. nidulans compared with the An-Uge3, strain
as determined by the Mantel-Cox log-rank test with pairwise comparison applying Bonferroni correction.
doi:10.1371/journal.ppat.1005187.g009
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with neutrophils deficient in NETosis, isolated either from a patient with CGD, or healthy
human neutrophils treated with two inhibitors of NETosis (DPI and MNase). Finally, the
increased virulence of the An-Uge3 strain was lost in mice with defective NADPH-oxidase.
These data are in agreement with multiple prior studies examining the interactions of A. fumi-
gatus and A. nidulans with neutrophils. A previous report suggested that killing of A. nidulans
by human neutrophils occurs predominately via a non-oxidative mechanism [35]. Similarly,
while susceptibility of A. nidulans to killing by NETs has been observed [26], A. fumigatus
growth was found to be only minimally inhibited by NET formation [27]. Our findings suggest
that differences in the expression of cell wall-associated GAG between A. nidulans and A. fumi-
gatus account for the differential susceptibility to NETs reported in these two studies.
Collectively, the results of these experiments suggest a model in which cell wall-bound Gal-
NAc-rich GAG functions as an extracellular capsule to enhance resistance to NETs, analogous
to bacterial capsular exopolysaccharide [11,36–38]. Although the mechanism by which exopo-
lysaccharide mediates resistance to NETs has not yet defined, the increased binding of NETs to
A. nidulans suggests that GAG may directly inhibit NET binding to hyphae. We have previ-
ously reported that the GalNAc component of GAG undergoes partial deacetylation, rendering
GAG a cationic glycan [39]. It is likely that this positive charge inhibits binding of cationic anti-
microbial peptides and histones within NETs resulting in increased resistant to NETosis. A
similar mechanism of resistance to cationic antimicrobial peptides by exopolysaccharide-medi-
ated electrostatic repulsion has been described in Staphylococcus epidermidis [40]. Further
work to clarify this mechanism is clearly required.
Why has A. fumigatus evolved this change in the composition of an exopolysaccharide and
the resulting increase in cell wall-associated GAG? As A. fumigatus is an environmental organ-
ism and only an incidental opportunistic pathogen of immunocompromised hosts, we specu-
late that selection for GalNAc-rich GAG was mediated through environmental pressures that
are unique to A. fumigatus. One hypothesis is that the production of a capsule-like hyphal
sheath could offer protection against competing microorganisms in the complex microbial
environment of decomposing organic matter, where A. fumigatus is commonly found. Studies
comparing the production and composition of GAG in strains of different environmental ori-
gin may be helpful in shedding light on this question.
Invasive aspergillosis can develop in non-neutropenic patients who are immunocompro-
mised due to corticosteroid or other immunosuppressive therapies, as well as in patients with
quantitative or qualitative defects in neutrophil function. The findings of this study are most
relevant to invasive aspergillosis in corticosteroid-treated or other non-neutropenic patients in
whom NET production is preserved. It is likely that there are other factors that contribute to
the spectrum of intrinsic virulence of Aspergillus species in different hosts. For example, GAG-
mediated resistance to NETs clearly plays no role in the pathogenesis in invasive aspergillosis
associated with neutropenia. In CGD patients, who are distinctly more susceptible to A. nidu-
lans, the inability to form NETs may have a greater effect on increasing susceptibility to infec-
tion with A. nidulans relative to A. fumigatus. However, further studies comparing the
pathogenesis of A. fumigatus and A. nidulans infection in CGD mice, or in other models of
invasive aspergillosis, are required to understand the role that GAG and other fungal factors
play in the pathogenesis of this disease.
Although our data suggests that cell wall-bound GAGmay contribute to differences in
intrinsic virulence in species other than A. fumigatus and A. nidulans, more work is needed to
confirm this hypothesis. The biochemical, antibody and lectin studies used to quantify GAG
were optimized with A. fumigatus and it is therefore possible that some differences in GAG
composition and structure other than GalNAc content could be missed by these techniques.
Also, while we observed similar low levels of cell wall-bound GAG in multiple laboratory and
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clinical isolates of A. nidulans strains, a larger screen of clinical and environmental isolates will
be required to more firmly establish the association between GalNAc-rich, cell wall-bound
GAG and intrinsic virulence. In addition, further mechanistic studies modulating GAG com-
position in these other species are required to confirm that the observations made in A. nidu-
lans are applicable to other species that produce GalNAc-poor GAG.
Modulating the composition of a single exopolysaccharide significantly enhanced the viru-
lence of a relatively non-pathogenic Aspergillus species in corticosteroid-treated mice through
enhancing resistance to NETs. This study highlights the importance of GAG as a key virulence
factor of A. fumigatus in this population and suggests that targeting this exopolysaccharide
may be an effective antifungal approach.
Materials and Methods
Fungal strains and growth conditions
A. nidulans strain A26 (Fungal Genetics Stock Center, Kansas City, MO, USA) was used as the
parent wild-type strain for all molecular manipulations. Other strains used in this study include
A. fumigatus strain Af293 (a generous gift from P. Magee, University of Minnesota, St. Paul,
MN, USA), the A. fumigatus Δuge3mutant [10], ΔstuAmutant [41] and clinical isolates of A.
flavus and A. niger (obtained from the McGill University Health Center, Montreal, QC, Can-
ada) and A. nidulans isolates from CGD patients (generous gifts from A. Warris and S. Hen-
riett, Radboud University Medical Center, Nijmegen, The Netherlands, and Adrian Zelazny US
National Institute of Health, USA). Unless otherwise noted, A. fumigatus strains and A. flavus
were maintained on YPD agar (Fisher Scientific), A. niger on potato-dextrose agar (Fisher Sci-
entific), and A. nidulans strains on Aspergillus minimum medium agar [10] at 37°C. For
growth in liquid medium, Brian medium [9] and phenol red-free RPMI 1640 (Wisent, Inc.)
were used as indicated. All growth media for A. nidulans strains were supplemented with biotin
(Fisher Scientific).
Molecular and genetic manipulations
Heterologous overexpression of uge3 and endogenous overexpression of ugeB in A. nidulans
was performed as previously described [42,43], with minor modifications. The open reading
frames of uge3 or ugeB were amplified by PCR from genomic DNA of A. fumigatus or A. nidu-
lans, respectively. The resulting PCR products were cloned downstream of the constitutive
gpdA promoter in plasmid pGFP-Phleo [42] [44] by replacing the GFP coding regions with
either uge3 or ugeB to yield plasmids pUge3-OX and pUgeB-OX, respectively (S1 Table). A.
nidulans was then transformed by spheroplasting, as previously described [45]. Gene overex-
pression was confirmed by real time RT-PCR [11].
Mutant characterization
Purification and analysis of GAG was performed as previously described [11]. Hyphae were
grown for 72h, and GAG was precipitated from culture supernatants with 2.5 volumes of etha-
nol. The GalNAc-rich insoluble fraction was collected by filtration on Nylon membrane and
washed with 60% ethanol (2.5 volume). Other volumes of ethanol precipitation was tested with
similar results. Composition of GAG was determined by gas chromatography after derivatiza-
tion to its alditol acetate, and quantified by hexose and hexosamine assays [9]. Conidial size
was measured by FACS analysis (BD LSR Fortessa) of conidia of each strain fixed with 4%
paraformaldehyde. Germination kinetics assay was performed by inoculating 1x105 conidia
per well in a 6-well plate, and incubating at 37°C, 5% CO2. At every hour, the number of
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germinated fungi was counted. For hyphal growth measurements, 1x106 conidia of indicated
strains were inoculated on agar plates and incubated at 37°C. Thallus diameter was measured
daily. Biofilm adherence was assessed on 24h grown hyphae of indicated strains by rigorously
washing and staining with 0.1% crystal violet for visualization, as previously described [10].
For scanning electron microscopy (SEM), fluorescein labeled soybean agglutinin (FITC-SBA)
lectin binding, and Fc-dectin-1 binding experiments, fungi were grown for the indicated times
in phenol red-free RPMI at 37°C, 5% CO2 incubation, fixed with either 2.5% gluteraldehyde or
4% PFA, and further processed [10]. Briefly, for SEM, samples were sequentially dehydrated in
ethanol, critical point dried, coated in Au-Pd, and imaged at 20,000X magnification (Hitachi,
Inc, or FEI Company), as previously described [10]. For FITC-SBA lectin or Fc-dectin-1 bind-
ing, fungi were grown in 96-well opaque plates (Thermo Fisher Scientific, Inc.) or clear-bottom
plates (Corning, Inc.) for 9–12 h, and immunostained with FITC-SBA (Vector Labs, Inc.), or
Fc-dectin-1 (a generous gift from Dr. G.D. Brown, Aberdeen, UK) followed by FITC labeled
anti-human IgG, FCγ fragment specific (Jackson ImmunoResearch Laboratories, Inc.). Fluo-
rescence of labeled samples was imaged by confocal microscopy (Olympus, Inc.) or relative
fluorescence measured at 495 nm excitation and 515 nm emission using Spectramax fluorime-
ter (Molecular Devices, LLC) or Infinite M1000 (Tecan, Inc.).
Virulence studies
For virulence studies in non-neutropenic mice, BALB/c or C57BL/6 mice, 6–8 weeks old, were
immunosuppressed with 5 doses of 10 mg of cortisone acetate per mouse (Sigma-Aldrich),
administered subcutaneously every other day starting on day -4 relative to infection [46]. For
studies in neutropenic mice, 6–8 weeks old C57BL/6 mice were treated on days -2 and +3 with
250 mg/kg of cortisone acetate (Sigma-Aldrich) intraperitoneally, and 250 mg/kg on day -2
and 200 mg/kg on day +3 of cyclophosphamide (Western Medical Supply). To prevent bacte-
rial infection, enrofloxacin was added to the drinking water. For studies in an NADPH oxi-
dase-deficient host, 8–12 week old male and female gp91phox deficient mice lacking functional
NADPH oxidase were used. All mice were infected intranasally with 1x106 conidia from A.
nidulans, An-Uge3, A. fumigatus or An-UgeB strains or treated with PBS alone as uninfected
controls. Mice were monitored for a period of 2 weeks for signs of illness, and moribund ani-
mals were euthanized or were sacrificed 4 days after infection for determination of fungal bur-
den and inflammation markers. At the time of sacrifice, bronchoalveolar lavage (BAL) fluid
was collected and then lungs were harvested and homogenized [10]. To determine pulmonary
leukocyte recruitment, Balb/c mice infected with the indicated fungal strains were sacrificed 4
days after infection and lungs were removed for collagenase (Sigma-Aldrich) digestion. Excised
lungs were washed in PBS, minced, and digested for 1 hour at 37°C in RPMI (Wisent) and 150
U/mL collagenase (Sigma-Aldrich) supplemented with 5% fetal bovine serum (Wisent). After
digestion, cells were washed and stained as mentioned, and post-fixed in 2% PFA. Cells from
BAL fluid or digested lungs were labeled with CD45, CD11b, CD11c, and Ly6G (BD Biosci-
ences), stained with Cell Viability Stain (eBiosciences), and counted using LSR Fortessa cell
analyzer (BD Biosciences) and analyzed using FlowJo VX software (Tree Star). Total leukocytes
were gated as CD45+ cells, while neutrophils were gated as CD11bhigh, CD11clow, and Ly6G+
cells. For histopathology studies, lungs from a subset of immunosuppressed BALB/c mice were
fixed in formalin. Thin sections were stained with hematoxylin and eosin (H&E) or periodic
acid Schiff (PAS) to visualize fungal elements. Caspase-3 immunohistopathology was per-
formed using an anti-capsase-3 antibody (Institute for Research in Immunology and Cancer,
Montreal, Canada). Immunohistochemistry staining with an anti-GAG antibody (Fontaine
et al., 2011) was performed to detect GAG in pulmonary sections (Institute for Research in
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Immunology and Cancer, Montreal, Canada). Pulmonary fungal burden was measured by
determining relative galactomannan levels by EIA (BioRad) using an internal standard [10].
Myeloperoxidase activity (Hycult Biotech), or cytokine production of TNF-α (eBiosciences,
Inc.), IL-1RA (R&D Systems, Inc), or IL-1β (Sigma-Aldrich) were measured by commercial
EIA following the manufacturer’s instructions. All procedures involving mice were approved
by the Los Angeles Biomedical Research Institute Animal Use and Care Committee; the Mon-
tana State University Animal Care Facility; or the McGill University Animal Care Committee,
and followed the National Institutes of Health guidelines for animal housing and care and the
guidelines established by the Canadian Council on Animal Care.
Morphometric analysis
PAS stained lung sections were digitally scanned at up to 400X magnification (Goodman Can-
cer Center, McGill University). Fungal lesions were identified by visual inspection and lesion
size and distance from airways were calculated using Spectrum (Apio, Inc) software. To ensure
unbiased data collection, readers were blinded to strain identity.
Neutrophil damage experiments
Indicated fungal strains were grown at 37°C, 5% CO2 for 6–9 h in either Brian medium or
Iscove’s Modified Dulbecco Medium (IMDM) adjusted to pH 6.5 (Life Technologies, Inc.) in a
24-well tissue culture treated plate (Corning, Inc.). For co-incubation experiments with neutro-
phils, blood samples obtained from healthy donors or from an individual with granulomatous
disease were purified to obtain polymorphonuclear cells (PMN), as previously described [47].
Briefly, white blood cells were separated using Ficoll gradation, followed by dextran sedimenta-
tion, and red blood cell lysis. Neutrophils isolated from donors were added to wells with young
hyphae and co-incubated for 12 h. After 12 h co-incubation, wells were washed with PBS, and
remaining neutrophils were lysed with distilled, endotoxin-free water (Fisher, Inc.). To quan-
tify hyphal injury, metabolic activity of fungi was measured by reduction of the tetrazolium
reagent XTT (Bioshop, Inc.), as previously described [48]. To inhibit NADPH-oxidase activity,
neutrophils were incubated with 25 μM diphenyleneiodonium (Sigma-Aldrich) for 1 h and
washed twice in medium prior to co-incubation with fungi. To test the ability of DNAse to dis-
rupt neutrophil extracellular traps, 10 Units of micrococcal nuclease (Sigma-Aldrich) were
added to each well at the time of co-incubation of hyphae and neutrophils. To ascertain the
effects of corticosteroid on neutrophil function in vitro, neutrophils were treated with 10μM
dexamethasone (Sigma-Aldrich) for 30 minutes prior to co-incubation. Effect of dexametha-
sone treatment on neutrophil function was measured by fungal killing quantified by reduction
of XTT and normalized to the metabolic activity of dexamethasone treated hyphae for each
strain.
To assess non-oxidative hyphal killing, 6–9 h grown young hyphae of indicated strains were
incubated with neutrophil lysates for 12 h, followed by XTT reduction assay, as previously
described [48]. Neutrophil lysates were prepared by subjecting the cells through a freeze-thaw
cycle, re-suspending in Brian medium pH 5.4 supplemented with 2% protease-free bovine
serum albumin (Bioshop, Inc.). Neutrophils were incubated with 25 μMDPI (Sigma, Inc.) for
1 h for the preparation of DPI-treated lysates. After mechanical disruption lysates were sepa-
rated from cell debris by centrifugation. The multiplicity of infection used for all assays, includ-
ing PMN lysates, was 1:100 (conidia to neutrophil). All procedures involving human subjects
were approved by the McGill University Research Ethics Board.
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To test susceptibility to reactive oxygen species, hyphae of the indicated strains were incu-
bated for 12 h with various concentrations of t-butyl peroxide (Sigma-Aldrich) ranging from 0
to 20 mM. Hyphal killing by t-butyl peroxide was measured by XTT reduction assay.
NET formation by neutrophils was detected by live imaging using confocal microscopy. Dif-
ferentiated HL-60 cells were co-incubated for 10–12 h with 6–9 h young hyphae of indicated
strains grown on coverslips. The coverslips were placed on slides containing 6–10 μL of phenol
red-free RPMI (Wisent, Inc.) containing 5 μg/mL of propidium iodide (Invitrogen, Inc.) and
imaged at an excitation wavelength of 543 nm laser using an Olympus Fluoview confocal
microscope (Olympus, Corp.). To ensure consistency between replicate imaging, all image
acquisitions were performed at room temperature, within 10–15 minutes.
Statistical analysis
For all mouse lung data analysis, unless indicated on the legend, the Mantel-Cox log-rank test
with pairwise comparison using Bonferroni correction was applied. For non-parametric data
with multiple comparisons, the Krustal-Wallis rank analysis, was performed, followed by
Dunn’s test for pairwise comparison. For all other data analysis, statistical significance was
determined by applying one-way ANOVA, partitioned with pairwise comparison using
Tukey’s test, and Bonferroni correction applied where applicable. All statistical analyses were
performed either with Prism (GraphPad, Inc.) or SAS (SAS Institute, Inc.) with significance
determined at p< 0.05. For all statistical analysis, n.s. denotes statistically no significant differ-
ences found.
Supporting Information
S1 Fig. Additional characterization of the Aspergillus species GAG production and surface
morphology. (A) Total secreted GAG normalized to biomass for the indicated species grown
in Brian medium. (B) Cell wall-associated GalNAc as detected by staining with FITC-conju-
gated soybean agglutinin (SBA) and quantified by fluorometry. (C) Formation of adherent bio-
films on tissue culture-treated polystyrene plates by the indicated A. fumigatus and A. nidulans
strains. After 24 hours growth, biofilms were washed and visualized by crystal violet staining.
(PDF)
S2 Fig. Additional characterization of the A. nidulans overexpression mutant phenotypes.
(A) Cell wall GalNAc detection by staining with FITC-conjugated soybean agglutinin (SBA).
SBA binding to mature hyphal mats of the indicated species was quantified by fluorometry at
495 nm. (B) Relative expression of uge3 in wild-type A. nidulans and A. fumigatus during
growth in Brian medium as measured by real-time RT-PCR. (C) Germination of A. nidulans
wild-type or the An-Uge3 strain in Brian medium over the indicated time period. (D) Conidia
size of the indicated strains quantified using flow cytometry. FSC indicates forward scatter.
Color scheme is as follows: yellow is wild-type A. nidulans, cyan is the An-Uge3 strain, and red
is the An-UgeB strain. (E) Efficiency of primers for amplification of the indicated genes relative
to the expression of reference gene Tef1 in the respective Aspergillus species. (F) Detection of β-
1,3-glucan exposure on the surface of hyphae by immunostaining with Fc-dectin-1 antibody
by confocal microscopy. Images were acquired using a 488 nm laser and detected by confocal
microscopy at 600X magnification. Scale bar represents 10 μm. (G) Hyphal growth as mea-
sured by radial growth of the indicated strains on Aspergillus minimal media plates. For all
panels: Data are represented as mean +/- SEM and  indicates a significant difference between
A. nidulans, and the An-Uge3 overexpression strain, p<0.05 by Kruskal-Wallis test with
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Dunn’s test for pairwise comparison.
(PDF)
S3 Fig. Additional characterization of host response. (A) Percent leukocytes from total
CD45+ cells in BAL fluid from Balb/c mice 4 days after infection with the indicated strains or
PBS control as measured by CD45 detection using flow cytometry. (B) Percent neutrophils
from total CD45+ cells in BAL fluid from of Balb/c mice 4 days after infection with the indi-
cated strains or PBS control as measured by Ly6G+, CD11bhigh, and CD11clow detection using
flow cytometry. (C) Myeloperoxidase activity in lungs of Balb/c mice infected with the indi-
cated strains or PBS control. (D-G) Total lung cytokine concentrations in Balb/c mice after 4
days of infection with the indicated strains or PBS control. Cytokines were measured by com-
mercial EIA for (D) TNF-α, (E) IL-1RA, (F) IL-17, or (G) IL-1β. (H) Percent viable total leuko-
cytes (identified as in A) as measured by viability staining using flow cytometry. (I) Percent
viable neutrophils (identified as in B) as measured by viability staining using flow cytometry.
(J) H&E stained lung sections from Balb/c mice infected with the indicated strains or PBS con-
trol. No significant differences in nuclear fragmentation of leukocytes were observed. For pan-
els A-G: Data are represented as median with interquartile ranges and  indicates a significant
difference between uninfected mice and mice infected with A. nidulans and the An-Uge3 over-
expression strain, p<0.05 by Krustal-Wallis test with Dunn’s test for pairwise comparison.
(PDF)
S1 Table. List of primers.
(PDF)
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